Toxoplasmosis Ppts and recent articles

Toxoplasmosis is an infectious disease caused by protozoan parasite Toxoplasma gondii.

Major  Human Parasites
Major human Protozoa.ppt

Eye manifestations  during pregnancy
By Dr  Mohamed Abusharifa, MD
Eye-manifestations-during-pregnancy.ppt

Ocular  Toxoplasmosis: A Common Manifestation of a Not-So-Common Disease
Mehdi  Shahidi, MD, Vidya  Sundareshan, MD, MPH
Ocular Toxoplasmosis .ppt

Toxoplasmosis 
by Pam  Holmes, Christy Stalcup, and Pam Yarborough
Toxoplasmosis.ppt

New Molecular  Based Methods of Diagnosis
Molecular Methods of Diagnosis.ppt

Toxoplasmosis
http://www.uic.edu/depts/ci/neonat05/Handouts/TH6-CMV05-Pyati.ppt

Infectious  Mononucleosis
http://cls.umc.edu/COURSES/CLS311/InfMono.ppt

Systemic  Diseases and the Eye
Systemic Diseases and the Eye

Anti-protozoal  drugs
http://elearning.najah.edu/OldData/pdfs/4518antiparasitics%201.ppt


Recently published 50 articles

1. Flow cytometry-based algorithm to analyze the anti-fixed Toxoplasma gondii tachyzoites IgM and IgG reactivity and diagnose human acute toxoplasmosis.
2. Two cases of disseminated toxoplasmosis.
3. The occurrence of microsporidial infections and toxoplasmosis in Slovak women.
4. A case of ocular toxoplasmosis imaged with spectral domain optical coherence tomography.
5. Disseminated toxoplasmosis in black-footed penguins (Spheniscus demersus).
6. Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis.
7. Serological IgG avidity test for ocular toxoplasmosis.
8. Cerebellar toxoplasmosis in HIV/AIDS infant: case report and review of the literature.
9. Southeastern Center for Emerging Biologic Threats Tabletop Exercise: Foodborne Toxoplasmosis Outbreak on College Campuses.
10. Preventive behavior for toxoplasmosis in pregnant adolescents in the state of Ceara, Brazil.
11. Significant reduction of Toxoplasma gondii brain cysts after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.
12. Toxoplasmosis Hospitalizations in the United States, 2008, and Trends, 1993-2008.
13. Is it all cerebral toxoplasmosis?
14. Effects of two antigens for IgM detection of toxoplasmosis.
15. Detection of toxoplasmosis in environmental samples at a wet market of a capital city centre.
16. Toxoplasmosis after allogeneic stem cell transplantation-a single centre experience.
17. Toxoplasma gondii: Protective immunity against toxoplasmosis with recombinant actin depolymerizing factor protein in BALB/c mice.
18. The role of serology in active ocular toxoplasmosis.
19. Toxoplasmosis: new challenges for an old disease.
20. Acute primary toxoplasmosis in travelers returning from endemic countries.
21. Risk factors for toxoplasmosis in pregnant women in central Italy.
22. Study of toxoplasmosis in 4466 pregnant women in Japan: anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors.
23. Frequency of Toxoplasmosis in Water Buffalo (Bubalus bubalis) in Trinidad.
24. The distribution of Toxoplasma gondii cysts in the brain of a mouse with latent toxoplasmosis: implications for the behavioral manipulation hypothesis.
25. Congenital toxoplasmosis: randomised comparison of strategies for retinochoroiditis prevention.
26. Diagnostic problems with congenital toxoplasmosis.
27. Toxoplasmosis in military personnel involved in jungle operations.
28. Molecular Diagnosis and Genotyping of Cases of Perinatal Toxoplasmosis in Mexico.
29. Molecular diagnosis of toxoplasmosis.
30. Effect of latent asymptomatic toxoplasmosis on glucose metabolism in brain of mice.
31. Serum levels of dehydroepiandrosterone sulfate (DHEAS) in ocular toxoplasmosis.
32. An atypical strain associated with congenital toxoplasmosis in Tunisia.
33. Hidden in plain view: emergence of progressive multifocal leukoencephalopathy after treatment of CNS toxoplasmosis.
34. A new MIC1-MAG1 recombinant chimeric antigen can be used instead of the Toxoplasma gondii lysate antigen in serodiagnosis of human toxoplasmosis.
35. Toxoplasma gondii in the peripheral blood of patients with ocular toxoplasmosis.
36. The placenta: a main role in congenital toxoplasmosis?
37. Oral oocyst-induced mouse model of toxoplasmosis: effect of infection with Toxoplasma gondii strains of different genotypes, dose, and mouse strains (transgenic, out-bred, in-bred) on pathogenesis and mortality.
38. Risk factors, clinical features, and outcomes of toxoplasmosis in solid-organ transplant recipients: a matched case-control study.
39. Maintained seroprevalence of toxoplasmosis among the residents of Jeju island, Korea.
40. Development and clinical evaluation of a rapid serodiagnostic test for toxoplasmosis of cats using recombinant SAG1 antigen.
41. DNA vaccination with a gene encoding Toxoplasma gondii GRA6 induces partial protection against toxoplasmosis in BALB/c mice.
42. Ocular findings in children with congenital toxoplasmosis.
43. Long-term ocular outcome in congenital toxoplasmosis: a prospective cohort of treated children.
44. Comparison of loop-mediated isothermal amplification (LAMP) and real-time PCR method targeting a 529-bp repeat element for diagnosis of toxoplasmosis.
45. Unrecognized ingestion of Toxoplasma gondii oocysts leads to congenital toxoplasmosis and causes epidemics in North America.
46. Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants.
47. Programs for control of congenital toxoplasmosis.
48. From human to number in the construction of toxoplasmosis from the logic of the human sciences.  
49. Potential immunomodulatory effects of latent toxoplasmosis in humans.
50. Adverse fetal outcome in the absence of timely prenatal diagnosis of congenital toxoplasmosis.